DNTH
Dianthus Therapeutics Inc

1,241
Mkt Cap
$1.85B
Volume
319,203.00
52W High
$45.46
52W Low
$13.37
PE Ratio
-12.36
DNTH Fundamentals
Price
$41.83
Prev Close
$43.15
Open
$43.40
50D MA
$39.23
Beta
0.92
Avg. Volume
779,515.74
EPS (Annual)
-$2.55
P/B
3.38
Rev/Employee
$79,935.90
Loading...
Loading...
News
all
press releases
Wedbush Reiterates Outperform Rating for Dianthus Therapeutics (NASDAQ:DNTH)
Wedbush restated an "outperform" rating and set a $46.00 target price on shares of Dianthus Therapeutics in a report on Monday...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Dianthus Therapeutics, Inc. $DNTH Shares Sold by 5AM Venture Management LLC
5AM Venture Management LLC cut its holdings in shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Free Report) by 4.2% during the second quarter, according to the company in its most recent filing...
MarketBeat·14d ago
News Placeholder
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Average Rating of "Moderate Buy" from Brokerages
Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Get Free Report) has earned an average rating of "Moderate Buy" from the ten analysts that are currently covering the firm, Marketbeat reports. One analyst...
MarketBeat·15d ago
News Placeholder
Dianthus Therapeutics (NASDAQ:DNTH) CFO Ryan Savitz Sells 20,000 Shares
Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Get Free Report) CFO Ryan Savitz sold 20,000 shares of the company's stock in a transaction on Thursday, December 4th. The stock was sold at an average...
MarketBeat·20d ago
News Placeholder
Dianthus Therapeutics (NASDAQ:DNTH) CFO Sells $903,600.00 in Stock
Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Get Free Report) CFO Ryan Savitz sold 20,000 shares of Dianthus Therapeutics stock in a transaction on Thursday, December 4th. The shares were sold at an...
MarketBeat·20d ago
News Placeholder
Dianthus Therapeutics (NASDAQ:DNTH) Reaches New 52-Week High - Here's Why
Dianthus Therapeutics (NASDAQ:DNTH) Hits New 1-Year High - Should You Buy...
MarketBeat·21d ago
News Placeholder
27,003 Shares in Dianthus Therapeutics, Inc. $DNTH Bought by XTX Topco Ltd
XTX Topco Ltd bought a new position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·21d ago
News Placeholder
Geode Capital Management LLC Has $9.04 Million Stock Position in Dianthus Therapeutics, Inc. $DNTH
Geode Capital Management LLC decreased its position in shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Free Report) by 6.2% in the 2nd quarter, according to the company in its most recent Form...
MarketBeat·22d ago
News Placeholder
Ensign Peak Advisors Inc Invests $2.50 Million in Dianthus Therapeutics, Inc. $DNTH
Ensign Peak Advisors Inc bought a new position in shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities...
MarketBeat·29d ago
News Placeholder
Dianthus Therapeutics (NASDAQ:DNTH) Reaches New 52-Week High - Should You Buy?
Dianthus Therapeutics (NASDAQ:DNTH) Sets New 12-Month High - Here's What Happened...
MarketBeat·1mo ago
<
1
2
...
>

Latest DNTH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.